Meet DISU ELIZABETH ARUMA, an Academic Staff of Lagos State University.





Pediatrics and Child Health


At the Pediatrics And Child Health department office

Visiting Hour

Appointment on Visitation important

Research Interest

Topic: Research Interest

Description: As a Paediatrician, my sub-specialty is neonatology, my research orientation has mainly been on newborn care, spanning maternal and intrapartum to neonatal period. I have also contributed to childhood research, particularly sickle cell disease and immunization. My first paper, written during my residency programme was a rare case report on neonatal ruptured appendix. Over the years I broadened the scope of my research to include HIV and its prevention from mother to child. More recently, in the last decade, I have contributed to building capacity of healthcare workers and I continue to explore educational intervention regarding improving the quality of health care delivery services in addition to exploring other clinical conditions of interest.


# Certificate SchoolYear
1. M.Sc (Public Health) University of London, (London School of Hygiene and Tropical Medicine) 2000

Current Research

Antenatal Corticosteroid Trial (ACT) in Improving Outcomes in Newborns

Research Details

WHO has a double-blind randomized trial involving 5 countries, which includes 2 centres in Nigeria in UCH Ibadan and OAUTH Ile -Ife with 7 and 6 institutions each. I am the principal investigator for the perinatal arm of this study at LASUTH in the UCH Ibadan group.

The aim of the study is to determine the efficacy and safety of the use of ACS in pregnant women in imminent preterm delivery. Our sample size in LASUTH is 120 and this research has been ongoing since December 2018. Furthermore, It is funded by the Bill and Melinda Gates Foundation.


1. Improve Maternal and newborn outcome of pregnant women with imminent preterm delivery 

2. To determine if ACS is effective in reducing neonatal mortality

3. To determine if ACS is safe in mothers and babies.


Patients are randomized to receive injectable dexamethazone or placebo at 12 hourly interval for 48 hour when recruited

Expected Results

1. Improved outcome in the health of neonates and mothers and reduced deaths 


DISU ELIZABETH is a Professor at the Department of Pediatrics and Child Health

DISU has a M.Sc in Public Health from University of London, (London School of Hygiene and Tropical Medicine)

The Numbers Say it AllWhy Choose Us